SHC RSI Chart
Last 7 days
2.3%
Last 30 days
5.0%
Last 90 days
-32.0%
Trailing 12 Months
-25.0%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 1.1B | 0 | 0 | 0 |
2023 | 987.5M | 976.2M | 990.6M | 1.0B |
2022 | 956.1M | 970.8M | 993.3M | 1.0B |
2021 | 842.1M | 880.9M | 907.1M | 931.5M |
2020 | 788.3M | 798.2M | 808.2M | 818.2M |
2019 | 0 | 0 | 0 | 778.3M |
Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index
Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>
Returns of $10,000 invested in:
Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224
Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 04, 2024 | rutz michael p | acquired | - | - | 34,270 | president of sterigenics |
Mar 04, 2024 | gtcr investment xi llc | sold | -158,283,000 | 14.3075 | -11,062,900 | - |
Mar 04, 2024 | petras michael b. jr. | sold | -14,362,900 | 14.3075 | -1,003,870 | chairman & ceo |
Mar 04, 2024 | klee ann r. | sold | -82,268 | 14.3075 | -5,750 | - |
Mar 04, 2024 | lyons jonathan m. | acquired | - | - | 41,124 | sr. vice president, cfo |
Mar 04, 2024 | warburg pincus & co. | sold | -237,424,000 | 14.3075 | -16,594,400 | - |
Mar 04, 2024 | petras michael b. jr. | acquired | - | - | 274,160 | chairman & ceo |
Mar 04, 2024 | rutz michael p | sold | -1,189,080 | 14.3075 | -83,109 | president of sterigenics |
Mar 04, 2024 | dimitrief alexander | acquired | - | - | 51,405 | svp, general counsel and sec. |
Mar 02, 2024 | petras michael b. jr. | sold (taxes) | -721,652 | 14.56 | -49,564 | chairman & ceo |
Which funds bought or sold SHC recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 17, 2024 | UNTITLED INVESTMENTS LP | added | 47.00 | 770,857 | 16,923,200 | 3.87% |
May 16, 2024 | JANE STREET GROUP, LLC | added | 606 | 3,381,580 | 4,219,090 | -% |
May 16, 2024 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -2.83 | -541,204 | 1,219,270 | -% |
May 16, 2024 | COMERICA BANK | added | 20.13 | -97,140 | 578,629 | -% |
May 16, 2024 | Wiser Advisor Group LLC | unchanged | - | -484 | 1,202 | -% |
May 16, 2024 | Pineridge Advisors LLC | reduced | -90.92 | -21,180 | 1,466 | -% |
May 15, 2024 | Repertoire Partners LP | added | 48.27 | 80,329 | 1,494,040 | 3.14% |
May 15, 2024 | Royal Bank of Canada | reduced | -85.61 | -817,000 | 93,000 | -% |
May 15, 2024 | Tower Research Capital LLC (TRC) | added | 60.22 | 15,393 | 123,823 | -% |
May 15, 2024 | LAKEWOOD CAPITAL MANAGEMENT, LP | new | - | 27,715,900 | 27,715,900 | 2.26% |
Unveiling Sotera Health Co's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Sotera Health Co)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
DHR | 196.9B | 23.7B | 44.73 | 8.29 | ||||
A | 45.2B | 6.7B | 36.57 | 6.71 | ||||
IDXX | 44.9B | 3.7B | 51.83 | 12.06 | ||||
DGX | 16.0B | 9.3B | 18.95 | 1.73 | ||||
NTRA | 13.1B | 1.2B | -35.76 | 10.81 | ||||
MEDP | 12.2B | 2.0B | 38.94 | 6.2 | ||||
CRL | 11.4B | 4.1B | 26.02 | 2.78 | ||||
EXAS | 9.3B | 2.5B | -38.69 | 3.67 | ||||
MID-CAP | ||||||||
GH | 3.1B | 603.7M | -6.73 | 5.14 | ||||
NEOG | 2.9B | 929.2M | 1.9K | 3.16 | ||||
SMALL-CAP | ||||||||
CDNA | 808.3M | 275.1M | -4.41 | 2.94 | ||||
ACRS | 84.8M | 31.1M | -1.1 | 2.73 | ||||
AWH | 33.0M | 9.2M | -2.24 | 3.6 | ||||
APDN | 2.5M | 5.5M | -0.2 | 0.45 | ||||
BIOC | 183.8K | 25.9M | -0.01 | 0.01 |
Sotera Health Co News
Income Statement (Quarterly) | |||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 |
Revenue | -20.0% | 248 | 310 | 263 | 255 | 221 | 252 | 249 | 267 | 237 | 241 | 226 | 252 | 212 | 217 | 200 | 213 | 188 | - |
Cost Of Revenue | -7.0% | 121 | 130 | 117 | 116 | 109 | 110 | 113 | 116 | 108 | 107 | 101 | 108 | 97.00 | 96.00 | 93.00 | 94.00 | 92.00 | - |
Gross Profit | -29.4% | 127 | 180 | 146 | 140 | 112 | 142 | 136 | 150 | 129 | 134 | 126 | 144 | 115 | 121 | 108 | 119 | 97.00 | - |
Operating Expenses | -2.8% | 74.00 | 76.00 | 70.00 | 76.00 | 78.00 | 82.00 | 73.00 | 79.00 | 75.00 | 68.00 | 60.00 | 65.00 | 69.00 | 68.00 | 60.00 | 57.00 | 52.00 | - |
S&GA Expenses | -3.6% | 58.00 | 60.00 | 54.00 | 60.00 | 62.00 | 66.00 | 57.00 | 63.00 | 60.00 | 52.00 | 44.00 | 50.00 | 52.00 | 53.00 | 46.00 | 43.00 | 37.00 | - |
EBITDA Margin | 8.3% | 0.37* | 0.34* | -0.11* | -0.12* | -0.12* | -0.10* | 0.33* | 0.33* | 0.34* | 0.32* | 0.27* | 0.27* | - | - | - | - | - | - |
Interest Expenses | 201.3% | 70.00 | 23.00 | 72.00 | 43.00 | 35.00 | 11.00 | 23.00 | 26.00 | 16.00 | 5.00 | 17.00 | 17.00 | 20.00 | 47.00 | 51.00 | 49.00 | 64.00 | - |
Income Taxes | -82.6% | 5.00 | 27.00 | 14.00 | 11.00 | 3.00 | -58.78 | 17.00 | 18.00 | 15.00 | 23.00 | 14.00 | 19.00 | 3.00 | 8.00 | -1.21 | 4.00 | -12.23 | - |
Earnings Before Taxes | -83.2% | 11.00 | 66.00 | 0.00 | 34.00 | 5.00 | -378 | 42.00 | 48.00 | 45.00 | 59.00 | 41.00 | 62.00 | 14.00 | -35.08 | -0.58 | 11.00 | -14.22 | - |
EBT Margin | 2.6% | 0.10* | 0.10* | -0.34* | -0.30* | -0.29* | -0.24* | 0.20* | 0.20* | 0.22* | 0.19* | 0.09* | 0.05* | - | - | - | - | - | - |
Net Income | -100.0% | - | 39.00 | -13.66 | 24.00 | 3.00 | -319 | 25.00 | 30.00 | 31.00 | 36.00 | 27.00 | 43.00 | 11.00 | -43.68 | 0.00 | 7.00 | -1.96 | - |
Net Income Margin | -2.6% | 0.05* | 0.05* | -0.31* | -0.27* | -0.26* | -0.23* | 0.12* | 0.13* | 0.14* | 0.13* | 0.04* | 0.01* | - | - | - | - | - | - |
Free Cashflow | -152.2% | -25.19 | 48.00 | -10.17 | -389 | -11.13 | 30.00 | 29.00 | 22.00 | 14.00 | 25.00 | 65.00 | 54.00 | - | - | - | - | - | - |
Balance Sheet | |||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 |
Assets | -2.3% | 3,060 | 3,130 | 3,037 | 3,075 | 3,414 | 3,118 | 2,811 | 2,840 | 2,836 | 2,790 | 2,743 | 2,851 | 2,777 | 2,761 |
Current Assets | -12.6% | 487 | 557 | 520 | 547 | 924 | 645 | 421 | 399 | 372 | 346 | 337 | 401 | 328 | 315 |
Cash Equivalents | -11.3% | 263 | 296 | 245 | 263 | 648 | 395 | 165 | 141 | 121 | 107 | 115 | 156 | 108 | 102 |
Inventory | 6.3% | 51.00 | 48.00 | 38.00 | 42.00 | 47.00 | 37.00 | 37.00 | 40.00 | 46.00 | 54.00 | 37.00 | 36.00 | 33.00 | 34.00 |
Net PPE | - | - | - | 884 | - | - | 775 | 704 | 700 | 669 | 651 | 624 | 624 | 612 | 610 |
Goodwill | -0.8% | 1,103 | 1,111 | 1,101 | 1,110 | 1,103 | 1,102 | 1,092 | 1,116 | 1,126 | 1,120 | 1,103 | 1,114 | 1,107 | 1,116 |
Liabilities | -2.1% | 2,630 | 2,687 | 2,659 | 2,657 | 3,053 | 2,767 | 2,204 | 2,204 | 2,194 | 2,203 | 2,217 | 2,328 | 2,311 | 2,307 |
Current Liabilities | -34.0% | 152 | 231 | 201 | 200 | 600 | 792 | 140 | 142 | 144 | 161 | 134 | 149 | 138 | 141 |
Long Term Debt | 0.0% | 2,225 | 2,224 | 2,223 | 2,222 | 2,222 | 1,747 | 1,747 | 1,746 | 1,745 | 1,744 | 1,743 | 1,838 | 1,838 | 1,825 |
LT Debt, Current | 0.2% | 5.00 | 5.00 | 5.00 | 5.00 | 4.00 | 197 | - | - | - | - | - | - | - | - |
LT Debt, Non Current | -100.0% | - | 2,224 | 2,223 | 2,222 | 2,222 | 1,747 | - | - | 1,745 | 1,744 | - | - | 1,838 | 1,825 |
Shareholder's Equity | -3.2% | 429 | 444 | 377 | 418 | 361 | 350 | 607 | 636 | 642 | 586 | 526 | 523 | 466 | 455 |
Retained Earnings | 1.0% | -648 | -654 | -693 | -679 | -702 | -705 | -386 | -411 | -441 | -472 | -508 | -535 | -578 | -589 |
Additional Paid-In Capital | 0.4% | 1,221 | 1,215 | 1,210 | 1,203 | 1,195 | 1,190 | 1,187 | 1,182 | 1,177 | 1,173 | 1,171 | 1,168 | 1,170 | 1,166 |
Shares Outstanding | 0.3% | 282 | 281 | 281 | 281 | 281 | 280 | 280 | 280 | 280 | 279 | 279 | 279 | - | - |
Minority Interest | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.00 | 2.00 |
Float | - | - | - | - | 1,871 | - | - | - | 1,948 | - | - | - | 2,403 | - | - |
Cashflow (Quarterly) | |||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 |
Cashflow From Operations | -91.4% | 9,699 | 113,123 | 41,849 | -336,575 | 33,871 | 101,926 | 67,779 | 58,289 | 49,967 | 66,351 | 80,938 | 78,097 | 56,159 | 21,845 | 46,053 | 46,997 | 5,690 | - |
Share Based Compensation | 5.6% | 8,663 | 8,204 | 8,378 | 8,373 | 7,288 | 6,256 | 4,616 | 5,801 | 4,538 | 3,381 | 3,547 | 3,493 | 3,449 | 6,968 | 901 | 1,393 | 1,725 | - |
Cashflow From Investing | 46.2% | -34,853 | -64,826 | -51,978 | -53,134 | -44,968 | -71,738 | -38,966 | -35,709 | -35,483 | -72,263 | -16,596 | -24,455 | -46,519 | -18,774 | -116,482 | -10,449 | -12,989 | - |
Cashflow From Financing | -214.8% | -11,941 | -3,793 | -3,454 | -710 | 273,916 | 199,244 | -400 | -634 | -449 | -1,782 | -103,414 | -8,307 | -3,783 | -10,529 | 90,479 | -55,825 | 49,307 | - |
Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Revenues: | ||
Total net revenues | $ 248,176 | $ 220,590 |
Cost of revenues: | ||
Total cost of revenues | 121,061 | 109,087 |
Gross profit | 127,115 | 111,503 |
Operating expenses: | ||
Selling, general and administrative expenses | 58,209 | 61,910 |
Amortization of intangible assets | 15,732 | 16,227 |
Total operating expenses | 73,941 | 78,137 |
Operating income | 53,174 | 33,366 |
Interest expense, net | 41,771 | 28,870 |
Foreign exchange (gain) loss | (572) | 347 |
Other expense (income), net | 961 | (1,253) |
Income before income taxes | 11,014 | 5,402 |
Provision for income taxes | 4,691 | 2,560 |
Net income | 6,323 | 2,842 |
Other comprehensive income (loss) net of tax: | ||
Pension and post-retirement benefits (net of taxes of $37 and $(17), respectively) | 113 | (51) |
Interest rate derivatives (net of taxes of $146 and $(3,396), respectively) | 419 | (9,251) |
Foreign currency translation | (27,706) | 11,257 |
Comprehensive (loss) income | $ (20,851) | $ 4,797 |
Earnings per share: | ||
Basic (in dollars per share) | $ 0.02 | $ 0.01 |
Diluted (in dollars per share) | $ 0.02 | $ 0.01 |
Weighted average number of shares outstanding: | ||
Basic (in shares) | 281,913 | 280,691 |
Diluted (in shares) | 284,062 | 282,977 |
Service | ||
Revenues: | ||
Total net revenues | $ 226,481 | $ 214,510 |
Cost of revenues: | ||
Total cost of revenues | 110,852 | 104,210 |
Product | ||
Revenues: | ||
Total net revenues | 21,695 | 6,080 |
Cost of revenues: | ||
Total cost of revenues | $ 10,209 | $ 4,877 |
Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 261,133 | $ 296,407 |
Restricted cash short-term | 1,687 | 5,247 |
Accounts receivable, net of allowance for uncollectible accounts of $3,925 and $4,689, respectively | 111,069 | 147,696 |
Inventories, net | 51,342 | 48,316 |
Prepaid expenses and other current assets | 53,663 | 53,846 |
Income taxes receivable | 8,285 | 5,732 |
Total current assets | 487,179 | 557,244 |
Property, plant, and equipment, net | 979,422 | 946,914 |
Operating lease assets | 22,517 | 24,037 |
Deferred income taxes | 4,883 | 4,993 |
Post-retirement assets | 29,502 | 28,482 |
Other assets | 42,881 | 41,242 |
Other intangible assets, net | 390,457 | 416,318 |
Goodwill | 1,102,851 | 1,111,190 |
Total assets | 3,059,692 | 3,130,420 |
Current liabilities: | ||
Accounts payable | 61,576 | 71,039 |
Accrued liabilities | 61,774 | 122,471 |
Deferred revenue | 12,882 | 13,492 |
Current portion of long-term debt | 4,808 | 4,797 |
Current portion of finance lease obligations | 1,490 | 8,771 |
Current portion of operating lease obligations | 5,303 | 5,934 |
Income taxes payable | 4,507 | 4,150 |
Total current liabilities | 152,340 | 230,654 |
Long-term debt, less current portion | 2,224,611 | 2,223,674 |
Finance lease obligations, less current portion | 90,858 | 63,793 |
Operating lease obligations, less current portion | 19,132 | 20,087 |
Noncurrent asset retirement obligations | 48,021 | 47,944 |
Deferred lease income | 18,223 | 18,762 |
Post-retirement obligations | 8,235 | 8,439 |
Noncurrent liabilities | 8,728 | 8,879 |
Deferred income taxes | 60,152 | 64,454 |
Total liabilities | 2,630,300 | 2,686,686 |
See Commitments and contingencies note | ||
Equity: | ||
Common stock, with $0.01 par value, 1,200,000 shares authorized; 286,037 shares issued at March 31, 2024 and December 31, 2023 | 2,860 | 2,860 |
Preferred stock, with $0.01 par value, 120,000 authorized; no shares issued at March 31, 2024 and December 31, 2023 | 0 | 0 |
Treasury stock, at cost (2,966 and 3,207 shares at March 31, 2024 and December 31, 2023, respectively) | (26,042) | (27,182) |
Additional paid-in capital | 1,220,547 | 1,215,178 |
Retained deficit | (648,117) | (654,440) |
Accumulated other comprehensive loss | (119,856) | (92,682) |
Total equity | 429,392 | 443,734 |
Total liabilities and equity | $ 3,059,692 | $ 3,130,420 |